Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts
Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan
Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling
FASEB: Focus on Research Funding, Not PR
MD Anderson Researcher Charged With Placing Ethylene Glycol In Colleague’s Coffee
Trending Stories
- Lei Zheng named executive director of Mays Cancer Center
- Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence - In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”